1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Generic Specialties Acquires Axcellerate Pharma

M&A Deal Summary

Generic Specialties Acquires Axcellerate Pharma

On May 17, 2016, Generic Specialties acquired life science company Axcellerate Pharma

Acquisition Highlights
  • This is Generic Specialties’ 1st transaction in the Life Science sector.
  • This is Generic Specialties’ 1st transaction in the United States.
  • This is Generic Specialties’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2016-05-17
Target Axcellerate Pharma
Sector Life Science
Buyer(s) Generic Specialties
Deal Type Add-on Acquisition

Target

Axcellerate Pharma

Piscataway, New Jersey, United States
Axcellerate Pharma LLC is a contract research organization and contract development and manufacturing organization (CRO/CDMO) focused on the development and manufacturing of sterile injectable products for generics and biologics.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Generic Specialties

Orlando, Florida, United States
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Generic Specialties, Inc. is a generic pharmaceutical company engaged in the manufacture, acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the U.S. prescription drug market.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal